To support vaccination campaigns in India and across the globe, Bharat Biotech has ramped up the manufacturing capacity of its COVID-19 vaccine, Covaxin, to 700 million doses per annum, the vaccine maker said on Tuesday.
Checked by McAfee. No virus detected.
Discuss
0 comments
Add new comment
500 characters left
Previous
1
…
1
…
Next
Bharat Biotech ramps up Covaxin producti...
File QR Code